The current report analyzes the global molecular diagnostic market. It also presents a view of the various segments of the market. The report discusses the drivers and challenges prevailing in the molecular diagnostics industry. It presents the competitive conditions prevailing in the global molecular diagnostic market, along with the profiles of major players.

1. View Report Details
Global Molecular Diagnostics Market
--------------------------------
2012

2. View Report Details
Executive Summary
Human being has evolved with an unending quest for exploration. With constant research in medical and other sciences,
molecular diagnostic tools and techniques were developed. Besides providing the medical work and a wider spectrum and
accuracy of test findings, these tests have also enabled researchers to establish new findings about human body which is
proving a boon against the rising complexities of health care in the present world. The global market of molecular diagnostics
has increased significantly in the recent past and is anticipated to expand invariably in the years to come. The market is
projected to record a CAGR of approximately 13.1% for the period spanning 2012-2014.
Testing for established infectious diseases such as HPV, CT/GC, and hepatitis, among others, represents the largest market
category in terms of revenue generation. However, with the realm of molecular diagnostic testing in cancer screening
undergoing a major change, the Oncology segment of the market will witness significant expansion in the times to come,
driving the overall market for molecular diagnostics. Geographically, the US is the largest regional market in worldwide
molecular diagnostics industry, with Europe and Japan trailing behind the US. While, these regions will continue to dominate
the molecular diagnostics landscape, the emerging regions are expected to experience the fastest growth.
The global molecular diagnostics market is presently characterized by growth in large value mergers and acquisitions and
shifting focus towards tailored therapy and personalized treatment, especially in the field of Oncology. Further, rising
incidences of genetic diseases unfolds new opportunities for genetic testing in the molecular diagnostics market. Further, the
ever escalating demand for better healthcare solutions, coupled with ageing world population and rising new incidences of
cancer are governing the global molecular diagnostics market growth, taking it to new heights. However, the global molecular
diagnostics marketplace continues to be plagued by challenges in the form of rising price pressures and growing regulatory
hurdles.
The intensely competitive and fragmented global molecular diagnostics market is mainly led by a few large players. Roche,
Qiagen, Gen-Probe, Novartis, Cepheid, and Becton Dickinson, are among the top notch players in the industry.
The current report analyzes the global molecular diagnostic market. It also presents a view of the various segments of the
market. The report discusses the drivers and challenges prevailing in the molecular diagnostics industry. It presents the
competitive conditions prevailing in the global molecular diagnostic market, along with the profiles of major players.

3. Global molecular diagnostics market witnessed steady growth in the past, across
various segments and regions…
Global Molecular Diagnostics Market: 2007-2011
 The molecular diagnostics segment held
approximately……..share of the global IVD market in
2011.
 Global IVD market is anticipated to grow steadily over a
long term.
 The global market for molecular diagnostics was valued at
about US$…….. billion in 2011, up by approximately
……% over the prior year. Furthermore, the market
registered a CAGR of approximately …….% during 2007-
2011.
Global Molecular Diagnostics Market Breakdown by
Regions (%): 2010
 The major revenue generating regions of the global
molecular diagnostics market are ……,………, and
…………….., collectively accounting for ………..% share of
the world market in 2010.
 Nearly………number of molecular diagnostics tests
products were approved by the FDA in the US in 2010, of
which approximately ………% were accounted
by………….product category.

4. Segmental breakup of global molecular diagnostics market…
Global Molecular Diagnostics Market Breakup by
Segments (%): 2010
 The global molecular diagnostics market can be
largely categorized into five sub segments, with
………….segment accounting for a lion’s share of
the overall market.
 The share of……….segment, nearly ……% as noted
in 2010, is anticipated to witness fastest growth in
the coming years, thus accounting for about ……..%
share by the end of 2015.
 The market for molecular diagnostics can be further
categorized on the basis of application or types of
diseases including ………, ………, ………, and
…….., among others.
Global Molecular HPV Testing Market: 2010-2013E
 Global Molecular HPV testing market was worth
US$......million in 2010, down by ……% over a year
ago period. The US is the largest molecular HPV
testing market, accounting for nearly
US$……..million sales during the same period.
 The global CT/GC market was valued at about
US$......million in 2011.

5. Long term growth expected in the global molecular diagnostics market supported
by numerous factors…
Global Molecular Diagnostic Market Share by Companies (%): 2011
• Roche is the leading player in the worldwide molecular
diagnostics market, with a share of about……..% in
2011, immediately followed by………. and ………..
• The global molecular diagnostics market is projected
to witness steady increase in the years to come,
reaching approximately US$...........billion by the end of
2014.
Global Molecular Diagnostics Market Forecast: 2010-2014F
• The factors responsible for steady and continuous
increase in the molecular diagnostics market, world
over, include ………………., ……………………….,
…………….., and ……………….., among others.
• The rising ………. and ……………testing market is
expected to significantly drive the global molecular
diagnostics market over a long tem.

6. View Report Details
Table of Contents
List of Charts and Tables
1. Overview List of Charts
1.1 In Vitro Diagnostics: Industry Overview IVD Market – Segments by Technology
1.2 Molecular diagnostics Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
2. Global Market Structure Global In-Vitro Diagnostics Market Revenues, 2004-2010
Growth in Global In-Vitro Diagnostics Market, 2005-2016F
2.1 Global IVD Market Global IVD Market Classification by Segments, 2011
Global IVD Market by Regions, 2010 & 2015F
2.1.1 Global Market Size Market Share of Leading Players in the Global IVD Market, 2010
2.1.2 Market Segmentation Global Molecular Diagnostics Market, 2007-2011
2.1.3 Competitive Scenario in IVD Market Global Molecular Diagnostics Market Breakup by Segments, 2010 &
2015F
2.2 Global Molecular Diagnostics Market Global Molecular Diagnostics Market Breakup by Application Areas, 2010
Global Molecular Diagnostics Market Breakdown by Regions, 2010
2.2.1 Global Market Size Number of Molecular Diagnostic Products Approved in the US, 2010
Global Molecular HPV Testing Market, 2010-2013E
2.2.2 Market by Segments
HPV Testing Market Penetration Rates in the US, 2010-2013E
2.2.3 Market by Regions
Global CT/GC Market Revenues, 2011
Global CT/GC Market Share by Leading Companies, 2011
2.3 Molecular Diagnostics Segments Analysis The US Market for Influenza Diagnostic Tests, 2010
Current Standards of Care in Various Therapeutic Areas, 2011
2.3.1 HPV Mergers & Acquisitions in Molecular Diagnostics Sector, 2008-2010
2.3.2 CT/GC Number of Genetic Tests and Laboratories Available Worldwide, 1993-
2.3.3 Influenza 2011
Global Ageing Population, 2005-2013F
3. Molecular Diagnostics - Market Dynamics Global Healthcare Spending, 2005-2010
Global Molecular Diagnostic Market Share by Companies, 2011
3.1 Trends & Developments Leading Players in PCR Based Global Molecular Diagnostics Market,
2010
3.1.1 Molecular Diagnostics in Oncology: Focus on Personalized Roche’s Revenues by Business Segments, 2011
Treatment Roche’s Revenues and Net Income, 2007-2011
3.1.2 Growing M&A Activity in the Molecular Diagnostics Novartis’ Revenues by Business Segments, 2011
Landscape Novartis’ Revenues and Net Income, 2007-2011
3.1.3 Emerging Korean Molecular Diagnostics Busine
3.1.4 Growth in Genetic Testing
3.1.5 Development of Industry’s First Real-Time “Multiplex
Quantification” Molecular Diagnostic Testing Technology

7. View Report Details
3.2 Growth Drivers Qiagen’s Revenues Share by Source of Revenues, 2011
Qiagen’s Revenues and Net Income, 2007-2011
3.2.1 Growing Ageing Population Gen-Probe’s Revenues Share by Source of Revenues, 2011
3.2.2 Rising Demand for Better Healthcare Options Qiagen’s Revenues and Net Income, 2007-2011
3.2.3 Rise in Healthcare Spending Global Molecular Diagnostics Market Forecast, 2010-2014F
3.3 Challenges List of Tables
3.3.1 Increasing Safety Regulations Patients Worldwide Waiting for Better Treatment Options, 2011
3..2 Escalating Price Pressure Non-PCR Amplification Processes
Global Peer Comparison in the Molecular Diagnostics Market, 2011
4. Molecular Diagnostics - Competitive Scenario Global Molecular Diagnostic Companies – Proprietary Technology
Dependent & Independent Variables, 2004-2010
Correlation Matrix
Competitive Overview
Model Summary – Coefficient of Determination
Market Share
Regression Coefficients Output
Peer Comparison
5. Company Profiles
5.1 Roche Holdings AG
Business Description
Key Financials
Business Strategies
Focus On Innovative Diagnostics
Leverage Expertise in Molecular Biology
5.2 Novartis AG
Business Description
Key Financials
Business Strategies
Sustained Investment in Innovation
Expansion in High-Growth Markets

8. View Report Details
5.3 Qiagen N.V.
Business Description
Key Financials
Business Strategies
Complete Automation Systems
Continuously Adding New Test Content
5.4 Gen-Probe Incorporated
Business Description
Key Financials
Business Strategies
Expanding Product Portfolio
Market Expansion within Clinical Diagnostics
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

9. View Report Details
Contact Us:
These are abridged and sanitized sample pages from the comprehensive report on the “Global Molecular Diagnostics Market”.
To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
Vikas Gupta T. +91-120-4130959
BD Manager C: +91-9811715635
vikas@konceptanalytics.com
www.konceptanalytics.com